Skip to main content

CITADEL ADVISORS LLC

Position in FENC — Fennec Pharmaceuticals Inc.

CIK 1423053 MIAMI, FL

Position in FENC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$763,593
-$181,108 QoQ
Shares Held
71,032
-53.8% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 104 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FENC Over Time

Shares Held

Position Value (USD)

Derivatives in FENC

reported options exposure · as of Mar 31, 2024
CallValue
$182,368
CallShares
16,400
PutValue
$1,112
PutShares
100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. FENC ranks #252 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FENC

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $763,593 71,032
2026-03-31 $944,701 153,610
2025-12-31 $1,538,067 199,749
2025-09-30 $1,006,162 107,496
2025-06-30 $388,298 46,783
2024-03-31 $1,112 100
2024-03-31 $182,368 16,400
2024-03-31 $541,699 48,714
2023-12-31 $2,244 200
2023-12-31 $109,956 9,800
2023-09-30 $102,961 13,710
2023-09-30 $96,879 12,900
2023-09-30 $3,755 500
2023-06-30 $88,300 10,000
2023-06-30 $531,566 60,200
2023-06-30 $347,248 39,326
2023-03-31 $293,446 35,270
2023-03-31 $71,552 8,600
2023-03-31 $777,920 93,500
2022-12-31 $26,880 2,800
2022-12-31 $1,412,160 147,100
2022-12-31 $269,317 28,054
2022-09-30 $315,900 39,000
2022-09-30 $126,974 15,676
2022-09-30 $86,670 10,700
2021-12-31 $65,445 14,874
2021-09-30 $157,314 16,700
2021-06-30 $83,106 11,400
2020-09-30 $81,810 13,500
2020-06-30 $98,530 11,800
2020-06-30 $159,485 19,100
2020-03-31 $62,964 10,600